{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T18:41:13Z","timestamp":1789756873511,"version":"4.0.1"},"reference-count":35,"publisher":"American Diabetes Association","issue":"9","content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2001,9,1]]},"abstract":"<jats:p>OBJECTIVE\u2014To describe risk factors associated with microalbuminuria (MA) in subjects with diabetes, investigate the predictive value of MA as a marker of risk for diabetic nephropathy (DN), and define risk factors associated with the development and progression of MA.<\/jats:p>\n                  <jats:p>RESEARCH DESIGN AND METHODS\u2014We conducted a prospective longitudinal study of 23 diabetic subjects with persistent MA and 209 diabetic subjects without MA who attended diabetes clinics at the University of Michigan Medical Center in 1989 and 1990. Both groups were examined at baseline and after 7 years. At baseline, urinary albumin\u2013to\u2013creatinine ratios were studied in random, first morning, and 24-h urine samples. At follow-up, a 12-h overnight urine sample was collected and analyzed for albumin and creatinine. At baseline, MA was defined by at least two separate urine specimens with albumin\u2013to\u2013creatinine ratios between 30 and 299 \u03bcg albumin per milligram of creatinine.<\/jats:p>\n                  <jats:p>RESULTS\u2014MA regressed in 56% of subjects with baseline MA without systematic application of corrective measures and developed in 16% of subjects without baseline MA. The predictive value positive of MA as a marker of risk for DN was 43%, and the predictive value negative was 77%. In the combined cohort, the incidence and progression of MA were significantly associated with poor glycemic control and duration of diabetes between 10 and 14 years.<\/jats:p>\n                  <jats:p>CONCLUSIONS\u2014MA may not be as sensitive and specific a predictor of DN as previously suggested. Other markers of risk for DN are needed for optimal clinical management.<\/jats:p>","DOI":"10.2337\/diacare.24.9.1560","type":"journal-article","created":{"date-parts":[[2007,3,5]],"date-time":"2007-03-05T17:51:27Z","timestamp":1173117087000},"page":"1560-1566","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":131,"title":["Does Microalbuminuria Predict Diabetic Nephropathy?"],"prefix":"10.2337","volume":"24","author":[{"given":"Bahman P.","family":"Tabaei","sequence":"first","affiliation":[{"name":"Internal Medicine and Epidemiology, University of Michigan Health System, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul S.","family":"Al-Kassab","sequence":"additional","affiliation":[{"name":"Internal Medicine and Epidemiology, University of Michigan Health System, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liza L.","family":"Ilag","sequence":"additional","affiliation":[{"name":"Internal Medicine and Epidemiology, University of Michigan Health System, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine M.","family":"Zawacki","sequence":"additional","affiliation":[{"name":"Internal Medicine and Epidemiology, University of Michigan Health System, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William H.","family":"Herman","sequence":"additional","affiliation":[{"name":"Internal Medicine and Epidemiology, University of Michigan Health System, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","reference":[{"key":"2022031214163120400_R1","doi-asserted-by":"crossref","unstructured":"Ritz E: Nephropathy in type 2 diabetes. Journal of Internal Medicine\u2008245:111\u2013126, 1999","DOI":"10.1046\/j.1365-2796.1999.00411.x"},{"key":"2022031214163120400_R2","doi-asserted-by":"crossref","unstructured":"Alzaid AA: Microalbuminuria in patients with NIDDM: an overview (Review). Diabetes Care\u200819:79\u201389, 1996","DOI":"10.2337\/diacare.19.1.79"},{"key":"2022031214163120400_R3","unstructured":"American Diabetes Association: Diabetic nephropathy (Position Statement). Diabetes Care\u200823(Suppl. 1):S69\u2013S72, 2000"},{"key":"2022031214163120400_R4","doi-asserted-by":"crossref","unstructured":"Mogensen CE: Microalbuminuria, blood pressure and diabetic renal disease: origin and development of ideas. Diabetologia\u200842:263\u2013285, 1999","DOI":"10.1007\/s001250051151"},{"key":"2022031214163120400_R5","doi-asserted-by":"crossref","unstructured":"Viberti GC, Jarrett RJ, Mahmud U, Hill RD, Argyropoulus A, Keen H: Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet\u2008i:1430\u20131432, 1982","DOI":"10.1016\/S0140-6736(82)92450-3"},{"key":"2022031214163120400_R6","doi-asserted-by":"crossref","unstructured":"Powrie JK, Watts GF, Ingham NA, Talmud PJ, Shaw KM: Role of glycaemic control in development of microalbuminuria in patients with insulin dependent diabetes. BMJ\u2008309:1608\u20131612, 1994","DOI":"10.1136\/bmj.309.6969.1608"},{"key":"2022031214163120400_R7","doi-asserted-by":"crossref","unstructured":"Ritz E, Reinhold O: Nephropathy in patients with type 2 diabetes mellitus. N Engl J Med\u2008341:1127\u20131133, 1999","DOI":"10.1056\/NEJM199910073411506"},{"key":"2022031214163120400_R8","doi-asserted-by":"crossref","unstructured":"Niskanen LK, Penttila I, Parviainen M, Uusitupa MIJ: Evolution, risk factors, and prognostic implications of albuminuria in NIDDM. Diabetes Care\u200819:486\u2013493, 1996","DOI":"10.2337\/diacare.19.5.486"},{"key":"2022031214163120400_R9","doi-asserted-by":"crossref","unstructured":"The Microalbuminuria Collaborative Study Group: Predictors of the development of microalbuminuria in patients with type 1 diabetes mellitus: a seven-year prospective study. Diabet Med  16: 918\u2013925, 1999","DOI":"10.1046\/j.1464-5491.1999.00182.x"},{"key":"2022031214163120400_R10","doi-asserted-by":"crossref","unstructured":"Klein R, Klein BE, Moss SE: Relation of glycemic control to diabetic microvascular complications in diabetes mellitus. Ann Intern Med\u2008124:90\u201396, 1996","DOI":"10.7326\/0003-4819-124-1_Part_2-199601011-00003"},{"key":"2022031214163120400_R11","unstructured":"Villar G, Garcia Y, Goicolea I, Vazquez JA: Determinants of development of microalbuminuria in normotensive patients with type 1 and type 2 diabetes. Diabet Metab\u200825:246\u2013254, 1999"},{"key":"2022031214163120400_R12","doi-asserted-by":"crossref","unstructured":"Warram JH, Scott LJ, Hanna LS, Wantman M, Cohen SE, Laffel LMB, Ryan L, Krolewski AS: Progression of microalbuminuria to proteinuria in type 1 diabetes: nonlinear relationship with hyperglycemia. Diabetes\u200849:94\u2013100, 2000","DOI":"10.2337\/diabetes.49.1.94"},{"key":"2022031214163120400_R13","doi-asserted-by":"crossref","unstructured":"Ismail N, Beckner B, Strtzelczyk P, Ritz E: Renal disease and hypertension in non-insulin-dependent diabetes mellitus. Kidney Int\u200855:1\u201328, 1999","DOI":"10.1046\/j.1523-1755.1999.00232.x"},{"key":"2022031214163120400_R14","doi-asserted-by":"crossref","unstructured":"Caramori ML, Fioretto P, Mauer M: The need for early predictors of diabetic nephropathy risk: Is albumin excretion rate sufficient? Diabetes\u200849:1399\u20131408, 2000","DOI":"10.2337\/diabetes.49.9.1399"},{"key":"2022031214163120400_R15","unstructured":"Mentel N, Haenszel W: Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst\u200822:719\u2013748, 1959"},{"key":"2022031214163120400_R16","doi-asserted-by":"crossref","unstructured":"Cochran WG: Some methods for strengthening the \u03c72 test. Biometrics\u200810:417\u2013451, 1954","DOI":"10.2307\/3001616"},{"key":"2022031214163120400_R17","doi-asserted-by":"crossref","unstructured":"Lachin JM: Biostatistical Methods: The Assessment of Relative Risks. New York, John Wiley and Sons, 2000","DOI":"10.1002\/9780470317051"},{"key":"2022031214163120400_R18","doi-asserted-by":"crossref","unstructured":"Miettinen OS: Estimability and estimation in case-reference studies. Am J Epidemiol\u2008103:226\u2013235, 1976","DOI":"10.1093\/oxfordjournals.aje.a112220"},{"key":"2022031214163120400_R19","doi-asserted-by":"crossref","unstructured":"Mogensen CE, Christensen CK: Predicting diabetic nephropathy in insulin-dependent diabetes. N Engl J Med\u2008311:89\u201393, 1984","DOI":"10.1056\/NEJM198407123110204"},{"key":"2022031214163120400_R20","doi-asserted-by":"crossref","unstructured":"Ellis D, LIoyd C, Becker DJ, Forrest KYZ, Orchard TJ: The changing course of diabetic nephropathy: low-density lipoprotein cholesterol and blood pressure correlate with regression of proteinuria. Am J Kidney Dis\u200827:809\u2013818, 1996","DOI":"10.1016\/S0272-6386(96)90518-1"},{"key":"2022031214163120400_R21","doi-asserted-by":"crossref","unstructured":"Bojestig M, Arnqvist HJ, Karlberg BE, Ludvigsson J: Glycemic control and progression in type 1 diabetic patients with microalbuminuria. Diabetes Care\u200819:313\u2013317, 1996","DOI":"10.2337\/diacare.19.4.313"},{"key":"2022031214163120400_R22","doi-asserted-by":"crossref","unstructured":"Almdal T, Norgaard K, Feldt-Rasmussen B, Deckert T: The predictive value of microalbuminuria in IDDM: a five-year follow-up study. Diabetes Care\u200817:120\u2013125, 1994","DOI":"10.2337\/diacare.17.2.120"},{"key":"2022031214163120400_R23","doi-asserted-by":"crossref","unstructured":"Rudberg S, Dahlquist G: Determinants of progression of microalbuminuria in adolescents with IDDM. Diabetes Care\u200819:369\u2013371, 1996","DOI":"10.2337\/diacare.19.4.369"},{"key":"2022031214163120400_R24","doi-asserted-by":"crossref","unstructured":"Gorman D, Sochett E, Daneman D: The natural history of microalbuminuria in adolescents with type 1 diabetes. J Pediatr\u2008134:333\u2013337, 1999","DOI":"10.1016\/S0022-3476(99)70459-2"},{"key":"2022031214163120400_R25","doi-asserted-by":"crossref","unstructured":"Levin SR, Coburn JW, Abraira C, Henderson WG, Colwell JA, Emanuele NV, Nuttall FQ, Sawin CT, Comstock JP, Silbert CK, for the Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type 2 Diabetes Feasibility Trial Investigators: Effect of intensive glycemic control on microalbuminuria in type 2 diabetes. Diabetes Care\u200823:1478\u20131485, 2000","DOI":"10.2337\/diacare.23.10.1478"},{"key":"2022031214163120400_R26","doi-asserted-by":"crossref","unstructured":"Rossing P: Promotion, prediction and prevention of progression of nephropathy in type 1 diabetes mellitus. Diabet Med\u200815:900\u2013919, 1998","DOI":"10.1002\/(SICI)1096-9136(1998110)15:11<900::AID-DIA709>3.0.CO;2-0"},{"key":"2022031214163120400_R27","doi-asserted-by":"crossref","unstructured":"Sikka R, Waters J, Moore W, Sutton DR, Herman WH, Aubert RE: Renal assessment practices and the effect of nurse case management of health maintenance organization patients with diabetes. Diabetes Care\u200822:1\u20136, 1999","DOI":"10.2337\/diacare.22.1.1"},{"key":"2022031214163120400_R28","doi-asserted-by":"crossref","unstructured":"Evans G, Greaves I: Microalbuminuria as predictor of outcome: shows promise but large prospective trials are needed. BMJ\u2008318:207\u2013208, 1999","DOI":"10.1136\/bmj.318.7178.207"},{"key":"2022031214163120400_R29","doi-asserted-by":"crossref","unstructured":"Forsblom CM, Groop PH, Ekstrand A, Totterman KJ, Sane T, Saloranta C, Groop L: Predictors of progression from normoalbuminuria to microalbuminuria in NIDDM. Diabetes Care\u200821:1932\u20131938, 1998","DOI":"10.2337\/diacare.21.11.1932"},{"key":"2022031214163120400_R30","doi-asserted-by":"crossref","unstructured":"Mathiesen ER, Ronn B, Storm B, Foght H, Deckert T: The natural course of microalbuminuria in insulin-dependent diabetes: a 10-year prospective study. Diabet Med\u200812:482\u2013487, 1995","DOI":"10.1111\/j.1464-5491.1995.tb00528.x"},{"key":"2022031214163120400_R31","doi-asserted-by":"crossref","unstructured":"The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med  329: 977\u2013986, 1993","DOI":"10.1056\/NEJM199309303291401"},{"key":"2022031214163120400_R32","doi-asserted-by":"crossref","unstructured":"UK Prospective Diabetes Study Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet\u2008352:837\u2013853, 1998","DOI":"10.1016\/S0140-6736(98)07019-6"},{"key":"2022031214163120400_R33","doi-asserted-by":"crossref","unstructured":"Sobngwi E, Mbanya JC, Moukouri EN, Ngu KB: Microalbuminuria and retinopathy in a diabetic population of Cameroon. Diabetes Res Clin Pract\u200844:191\u2013196, 1999","DOI":"10.1016\/S0168-8227(99)00052-2"},{"key":"2022031214163120400_R34","doi-asserted-by":"crossref","unstructured":"Bruno G, Cavallo-Perin P, Bargero G, Borra M, Calvi V, D\u2019Errico N, Deambrogio P, Pagano G: Prevalence and risk factors for micro-and macroalbuminuria in an Italian population-based cohort of NIDDM subjects. Diabetes Care\u200819:43\u201347, 1996","DOI":"10.2337\/diacare.19.1.43"},{"key":"2022031214163120400_R35","doi-asserted-by":"crossref","unstructured":"Campos-Pastor MM, Escobar-Jimenez F, Mezquita P, Herrera-Pombo JL, Hawkins-Carranza F, Luna JD, Azriel S, Serraclara A, Rigopoulos M: Factors associated with microalbuminuria in type 1 diabetes mellitus: a cross-sectional study. Diabetes Res Clin Pract\u200848:43\u201349, 2000","DOI":"10.1016\/S0168-8227(99)00133-3"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/24\/9\/1560\/589101\/1560.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/24\/9\/1560\/589101\/1560.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T09:16:43Z","timestamp":1647076603000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/24\/9\/1560\/21355\/Does-Microalbuminuria-Predict-Diabetic-Nephropathy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,9,1]]},"references-count":35,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2001,9,1]]}},"URL":"https:\/\/doi.org\/10.2337\/diacare.24.9.1560","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,9,1]]}}}